©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 21, 2015; 21(39): 11053-11076
Published online Oct 21, 2015. doi: 10.3748/wjg.v21.i39.11053
Published online Oct 21, 2015. doi: 10.3748/wjg.v21.i39.11053
Endocrine causes of nonalcoholic fatty liver disease
Laura Marino, François R Jornayvaz, Service of Endocrinology, Diabetes and Metabolism, Lausanne University Hospital, 1011 Lausanne, Switzerland
Author contributions: Both authors wrote the manuscript.
Conflict-of-interest statement: The authors declare no conflict of interests.
Correspondence to: François R Jornayvaz, MD, Service of Endocrinology, Diabetes and Metabolism, Lausanne University Hospital, Rue du Bugnon 46, 1011 Lausanne, Switzerland. francois.jornayvaz@chuv.ch
Telephone: +41-213140622 Fax: +41-213140630
Received: April 14, 2015
Peer-review started: April 16, 2015
First decision: May 18, 2015
Revised: June 11, 2015
Accepted: August 28, 2015
Article in press: August 28, 2015
Published online: October 21, 2015
Processing time: 187 Days and 11.4 Hours
Peer-review started: April 16, 2015
First decision: May 18, 2015
Revised: June 11, 2015
Accepted: August 28, 2015
Article in press: August 28, 2015
Published online: October 21, 2015
Processing time: 187 Days and 11.4 Hours
Core Tip
Core tip: The review discusses the links between nonalcoholic fatty liver disease and endocrine diseases, from common ones such as type 2 diabetes and polycystic ovary syndrome to rare disorders such as growth hormone deficiency. The pathophysiological mechanisms underlying these associations are described.